SEC Form 4 · accession 0000899243-15-004505
Baxalta Inc · BXLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David D. Meek
Officer — EVP and President, Oncology
Period of report
Sep 2, 2015
Accepted (ET)
Sep 4, 2015 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001620546
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per shareF1 | Sep 2, 2015 | F | 791 | $35.03 | D | 24,277 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock granted on September 2, 2014.